RA CAPITAL MANAGEMENT, L.P. Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$1.3T
Holdings
31
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,512,049 | $301.2B | 23.08% | |
| 2 | ASNDASCENDIS PHARMA A S | 4,240,536 | $277.3B | 21.25% | |
| 3 | —AVEXIS INC | 1,028,289 | $127.1B | 9.74% | |
| 4 | —MYOVANT SCIENCES LTD | 2,830,455 | $60.2B | 4.61% | |
| 5 | SG7SAGE THERAPEUTICS INC | 353,133 | $56.9B | 4.36% | |
| 6 | IFRXINFLARX NV | 1,620,653 | $46.7B | 3.58% | |
| 7 | —ZOGENIX INC | 1,145,268 | $45.9B | 3.51% | |
| 8 | —DICERNA PHARMACEUTICALS INC | 3,933,489 | $37.6B | 2.88% | |
| 9 | SCPHSCPHARMACEUTICALS INC | 2,857,143 | $35.4B | 2.71% | |
| 10 | —ENDOCYTE INC | 3,881,793 | $35.3B | 2.70% | |
| 11 | TGTXTG THERAPEUTICS INC | 2,472,344 | $35.1B | 2.69% | |
| 12 | KALAKALA PHARMACEUTICALS INC | 2,113,236 | $33.5B | 2.56% | |
| 13 | BCRXBIOCRYST PHARMACEUTICALS | 6,984,692 | $33.3B | 2.55% | |
| 14 | —RA PHARMACEUTICALS INC | 3,851,808 | $20.5B | 1.57% | |
| 15 | SLDBSOLID BIOSCIENCES INC | 2,689,444 | $20.2B | 1.55% | |
| 16 | APLSAPELLIS PHARMACEUTICALS INC | 900,000 | $19.9B | 1.52% | |
| 17 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,525,000 | $16.4B | 1.25% | |
| 18 | —AVEO PHARMACEUTICALS INC | 5,062,759 | $14.7B | 1.12% | |
| 19 | KALVKALVISTA PHARMACEUTICALS INC | 1,441,070 | $13.7B | 1.05% | |
| 20 | GYRECATALYST BIOSCIENCES INC | 514,917 | $13.3B | 1.02% | |
| 21 | IOVAIOVANCE BIOTHERAPEUTICS INC | 659,059 | $11.1B | 0.85% | |
| 22 | SPROSPERO THERAPEUTICS INC | 741,647 | $10.6B | 0.81% | |
| 23 | —BIOHAVEN PHARMACTL HLDG CO LTD | 363,636 | $9.4B | 0.72% | |
| 24 | VKTXVIKING THERAPEUTICS INC | 2,029,396 | $8.9B | 0.68% | |
| 25 | —SUNESIS PHARMACEUTICALS INC | 2,471,456 | $6.7B | 0.52% | |
| 26 | KRYSKRYSTAL BIOTECH INC | 496,071 | $5.0B | 0.38% | |
| 27 | GLYCEURGLYCOMIMETICS INC | 253,547 | $4.1B | 0.32% | |
| 28 | —PROTEON THERAPEUTICS INC | 1,337,462 | $3.3B | 0.26% | |
| 29 | GTHXEURG1 THERAPEUTICS INC | 40,000 | $1.5B | 0.11% | |
| 30 | —EDGE THERAPEUTICS INC | 285,491 | $337.0M | 0.03% | |
| 31 | CTIC1USDCTI BIOPHARMA CORP | 56,951 | $222.0M | 0.02% |